Clinical trials have four phases that test the safety and efficacy of various medical treatments on participants. Health insurance may cover some or all of the cost of participating in a clinical ...

GEN announces approval in the Netherlands to initiate patient enrollment in April 2026 for the Phase II Proof of ...

MVID has a lethal natural history requiring life-sustaining parenteral support (PS), which includes total parenteral ...

Announcing a new article publication for BIO Integration journal. Clinical trials bridge basic research and clinical application, serving as essential steps in drug development.

START will leverage Trialing’s platform to distribute curated information on ongoing early-phase oncology trials.

TenoMiR to Progress to Phase 3 Study for Lateral Epicondylitis, Making it One of the Most Advanced microRNA Clinical Programs GLASGOW, Scotland, March 19, 2026 (GLOBE NEWSWIRE) -- Causeway ...

AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the ...

BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Two videoconferences will be held tomorrow, on Tuesday November 19, 2024, the first in French at 10:00 am CET and the second in English at 4:00 pm ...

Avance Clinical, a global full-service CRO headquartered in Australia dedicated to servicing biotech, announces the appointment of Liahna Toy as Senior Vice President & Head of Early Phase Center of ...

Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in a phase III clinical study (JSKN016-301) evaluating JSKN016, a novel TROP2/HER3 bispecific ...